Podcasts about IMA

Three-month investigation yields no over-financing evidence but removes 25 sub-agents as IMA introduces new requirements.View the full article here.Subscribe to the IMI Daily newsletter here. 

Rose is joined by two incredibly accomplishedvoices in the fight for medical transparency and parental rights. Dr. Lynn Fynn is a retired Infectious Disease Physician and member of the Independent Medical Alliance—focused on clinical research and innovation. She is joined by Dr. KatLindley, a respected Family Practice Physician, Senior Fellow and Director at the Independent Medical Alliance.They're both deeply involved in advocacy around vaccine policy—especially where it impacts our most vulnerable: children and pregnant women. The IMA recently launched its “Smart Moms” campaign. It's a powerful grassroots movement calling for evidence-baseddecisions around vaccine safety. And now, according to TheWall Street Journal, both the CDC and HHS are reportedly moving toward ending their recommendations for mRNA vaccines in children and pregnant women.We talk about the growing body of research, including a 2025 study that found a 620% increase in the risk of myocarditis among young men following mRNA vaccination—along with a 175% rise in pericarditis. And we explore what's happening to young men post-vaccination, beyond the infant and pediatric concerns.More and more parents are expressing concern about the current newborn and infant vaccine schedule, describing it as aggressive. We'll dig into what that schedule actually looks like, and whether pediatricians are becoming more open to flexibility.These vaccine-related concerns are hopefully gettingthe thoughtful attention they deserve. For More Information: https://imahealth.orgPlease Support this Podcast:www.mypillow.comPromo Code: Rosewww.mypatriot.com/rosewww.americansforprosperity.orghttps://wordmarketingservices.com/Rose's Ministry: www.sheiscalledbyhim.com  sign up for a free newsletter

Never miss another webinar. Sign up here: https://imahealth.org/weekly-webinars/Learn more: https://imahealth.org/red-light-therapy-science/Red light therapy is lighting up the wellness world—but what's real and what's just hype? From full-body saunas to simple at-home devices, this promising treatment is gaining traction fast.This week, IMA Senior Fellow Dr. Ryan Cole hosts a bright and timely conversation with IMA Senior Fellow Dr. Kristina Carman and special guest Dr. Brooke Miller to explore the real sciecne behind red light therapy. They'll break down how light affects our cells, the potential benefits for inflammation, arthritis, energy, and even cancer support—and what's myth versus medically meaningful.Whether you're a curious newcomer or a seasoned biohacker, this episode sheds light on one of the most exciting new tools in modern wellness.Keywords/Tags: red light therapy science, science behind red light therapy​, science of red light therapy• Donate: https://imahealth.org/donate/• Follow: https://imahealth.org/contact/• Webinar: https://imahealth.org/category/weekly-webinars/• Treatment: https://imahealth.org/treatment-protocols/• Medical Disclaimer: https://imahealth.org/about/terms-and-conditions/About IMA (Formerly FLCCC Alliance)The Independent Medical Alliance™ is a nonprofit, 501(c)(3) organization and coalition of physicians, nurses, and healthcare professionals united by a mission to restore trust and transparency in healthcare. The organization's mission is one driven by Honest Medicine™ that prioritizes patients above profits and emphasizes long-term wellness and disease prevention through empowerment of both physicians and their patients. With a focus on evidence-based medicine, informed consent, and systemic reform, IMA is driving a movement to create a more compassionate and effective healthcare system.For more information about the Independent Medical Alliance, visit www.IMAhealth.org

Imaćeš utisak da su neke aktivnosti lakše, a neke teže, ali je bitno da znaš koja je tvoja slaba tačka kada učiš engleski. Preslušaj ovu epizodu. Ukoliko želiš da učiš engleski u English Lane školi sa Zoranom, pogledaj kako da se prijaviš ovde: https://englishlane.net/onlineskola/ Link ka ovoj epizodi podkasta na blogu: https://englishlane.net/onlineskola/186-slaba-tacka-kada-ucis-engleski/

Dagens episode av SK (slang for Skumma Kultur) kan kun beskrives slik: Det er juni måned i 2014. Det er sommer og varmt i været. Bilen er tilsvarende glodvarm. Du, mor og far skal på hytta. Et par timer inn i bilturen skjer det som må skje. Mamma og pappa begynner å krangle. De roper, skriker, lugger og slår og muter hverandres mikrofoner. Du sitter skrekkslagen i baksetet og følger med. Et par ganger ser du opp fra din Nintendo DS for å si noe, men mor gir deg sitt drepende blikk og muter mikrofonen din. Mor og far snakker om voksenting som badesko, VG-lista og Heddadagene. Du prøver å lette litt på stemningen med å nevne Instagram reels og petonque, det var en tabbe. Mor og far et straks tilbake i tøttene og volden fortsetter. Helt til sist prøver mor å få far til forbedre seg i løpet av sommeren. Andreas ender opp med  å kle seg ut i kostyme på natten i Sofienbergsparken.Takk til Ima på teknikk.

In this episode, we chat with Ali Haji, CEO of American Tungsten Ltd, a listed Canadian exploration company focused on advancing high-grade magnetite mineral properties with its flagship asset, the IMA Mine Project in Idaho. Ali has over 20 years in metals and mining, investment management, and publicly-listed capital markets experience, where he has served a variety of senior leadership roles within the mining industry. Ali discusses the background to American Tungsten, why it's important in today’s industrial and technological landscape, US funding and regulatory controls, and what the company is looking to achieve in the long term KEY TAKEAWAYS The company is primarily focused on the IMA Mine Project in Idaho, which is a past producer of tungsten and aims to bring production back online within 18 months. The mine has a significant historical resource and is located in a strong mining jurisdiction. Tungsten is a critical metal used in various military and industrial applications, including armour, ammunition, aerospace components, and microchips. Its high melting point and strength make it essential in many technologies, highlighting the need for domestic production. The current U.S. administration prioritises critical minerals, including tungsten, which has led to potential benefits for American Tungsten, such as fast-tracked permitting and access to grants and low-interest loans to support production efforts. The leadership team includes individuals with extensive experience in the mining sector and government funding, which positions American Tungsten favourably to navigate regulatory processes and secure necessary funding for development. Key upcoming events for American Tungsten include the release of a 43-101 resource statement, exploration drilling, and a bulk sample to assess metallurgy. These developments are expected to enhance the company's resource profile and expedite the path to production. BEST MOMENTS "Tungsten is the second hardest element on the periodic table, used to strengthen alloys and has a very high melting point at 2500 degrees centigrade." "We believe that at IMA, we can be the fastest to bring tungsten production back online in North America." "The goal is to bring back a lot of the production that was mothballed in 2015 when the Chinese flooded the market with cheap tungsten." "Our path to production is quicker than anybody else in the space. Our resource is well defined with the expectation for it to grow." VALUABLE RESOURCES Mail: rob@mining-international.org LinkedIn: https://www.linkedin.com/in/rob-tyson-3a26a68/ X: https://twitter.com/MiningRobTyson YouTube: https://www.youtube.com/c/DigDeepTheMiningPodcast Web: http://www.mining-international.org This episode is sponsored by Hawcroft, leaders in property risk management since 1992. They offer: Insurance risk surveys recognised as an industry standard Construction risk reviews Asset criticality assessments and more Working across over 600 sites globally, Hawcroft supports mining, processing, smelting, power, refining, ports, and rail operations. For bespoke property risk management services, visit www.hawcroft.com GUEST SOCIALS https://americantungstencorp.com/ https://www.linkedin.com/company/americantungstencorp/ https://www.youtube.com/@americantungstencorp https://www.facebook.com/americantungstencorp/ https://www.instagram.com/americantungstencorp https://x.com/amtungsten ABOUT THE HOST Rob Tyson is the Founder and Director of Mining International Ltd, a leading global recruitment and headhunting consultancy based in the UK specialising in all areas of mining across the globe from first-world to third-world countries from Africa, Europe, the Middle East, Asia, and Australia. We source, headhunt, and discover new and top talent through a targeted approach and search methodology and have a proven track record in sourcing and positioning exceptional candidates into our clients' organisations in any mining discipline or level. Mining International provides a transparent, informative, and trusted consultancy service to our candidates and clients to help them develop their careers and business goals and objectives in this ever-changing marketplace. CONTACT METHOD rob@mining-international.org https://www.linkedin.com/in/rob-tyson-3a26a68/ Podcast Description Rob Tyson is an established recruiter in the mining and quarrying sector and decided to produce the “Dig Deep” The Mining Podcast to provide valuable and informative content around the mining industry. He has a passion and desire to promote the industry and the podcast aims to offer the mining community an insight into people’s experiences and careers covering any mining discipline, giving the listeners helpful advice and guidance on industry topics. This Podcast has been brought to you by Disruptive Media. https://disruptivemedia.co.uk/

Inovação na gestão pública, levando projetos que incorporem inteligência e tecnologia e façam a diferença na vida dos cidadãos em municípios de diferentes perfis, sempre entendendo as necessidades de cada administração. A IMA – Informática dos Municípios Associados – é uma das maiores empresas municipais de tecnologia do País, cuja maior acionista é a Prefeitura de Campinas, especializada em unir análise de dados de ponta com inovação, formatando iniciativas de transformação que estão em andamento em diferentes cidades brasileiras, muitas delas premiadas e em parceria com big techs - de redes de alto desempenho até a implementação de mais de 200 sistemas diferentes de governo digital integrados a dados. No Start Eldorado dessa semana, o apresentador Daniel Gonzales recebe o diretor-presidente da IMA, Elias Tavares, para uma conversa sobre cidades inteligentes e inovação. Com transmissão pela Rádio Eldorado FM 107,3 para toda Grande São Paulo, site, aplicativo, canais digitais e assistente de voz, o Start vai ao ar todas as quartas-feiras, às 21h.See omnystudio.com/listener for privacy information.

Never miss another webinar. Sign up here: https://imahealth.org/weekly-webinars/ Learn more: https://imahealth.org/medical-case-against-transitioning-minors/As gender transition procedures among youth become more common, a growing number of doctors are raising serious concerns—medical, ethical, and human rights alike. Can minors truly consent to irreversible medical interventions? Urgent questions demand honest answers.This week, IMA Senior Fellow Dr. Ryan Cole hosts a powerful panel featuring IMA Senior Fellows Dr. Kimberly Milhoan and Dr. Katherine Welch. Together, they'll lay out the medical case against transitioning minors—from the lack of informed consent to the long-term physical and psychological harm. Both guests bring deep clinical experience serving children and vulnerable populations—and both are sounding the alarm.This discussion continues a powerful conversation first sparked during a panel at the 2025 IMA Conference. While the topic is often politicized, IMA approaches it from a medical and ethical standpoint. Our mission is rooted in patient-centered care and medical transparency, and protecting minors from irreversible harm fits squarely within that commitment.Keywords/Tags: gender transition for minors, gender transition minors, medical transition for minors• Donate: https://imahealth.org/donate/• Follow: https://imahealth.org/contact/• Webinar: https://imahealth.org/category/weekly-webinars/• Treatment: https://imahealth.org/treatment-protocols/• Medical Disclaimer: https://imahealth.org/about/terms-and-conditions/About IMA (Formerly FLCCC Alliance)The Independent Medical Alliance™ is a nonprofit, 501(c)(3) organization and coalition of physicians, nurses, and healthcare professionals united by a mission to restore trust and transparency in healthcare. The organization's mission is one driven by Honest Medicine™ that prioritizes patients above profits and emphasizes long-term wellness and disease prevention through empowerment of both physicians and their patients. With a focus on evidence-based medicine, informed consent, and systemic reform, IMA is driving a movement to create a more compassionate and effective healthcare system.For more information about the Independent Medical Alliance, visit www.IMAhealth.org

But whose priorities are we talking about?Who identifies the business issues that Insight could investigate?Ho much agency does the Insight have in allocating its own time, budget and focus?In this episode we look at:The Insight prioritisation matrix (1.30)The paramount importance of proactivity (4.17)Making essential choices (7.40)The daily discipline of prioritisation (10.55)Value-based prioritisation (14.04)A commercial mindset (17.50) Please listen to find out more! This is episode 72 of the Transforming Insight podcast. If you have the ambition to transform your Insight team and the role it plays in your organisation, please tune in to future episodes. Not only will we explore the secrets of successful corporate Insight teams and their leaders, as outlined in James Wycherley's books, Transforming Insight and The Insight Leader's Playbook, we will also talk to senior corporate Insight leaders, delve into books that have inspired us, and discuss new best practice research carried out with the IMA's corporate members.You won't want to miss this! So please subscribe - and thank you for listening.  About James Wycherley, the author of Transforming InsightJames Wycherley was Director of Customer Insight and Analytics at Barclays Bank from 2005 to 2015 when he became Chief Executive of the Insight Management Academy (IMA). He published his first book, Transforming Insight, in 2020, and his second, The Insight Leader's Playbook, in 2025, and he hosts the Insight forums and the Transforming Insight podcast.An entertaining keynote speaker, he has presented over 50 times at Quirk's events, a global record, and has provided thought leadership in the UK, USA, Europe, Canada, Australia, India and the Middle East.The Insight Management Academy is the world's leading authority on transforming corporate Insight teams, and its vision is to inspire and support every Insight leader to transform the impact of Insight in their organisation. Resources:If you would like more information on any of the ideas discussed in this episode of the Transforming Insight podcast, please visit www.insight-management.org DisclaimerThe Transforming Insight podcast is published by the Insight Management Academy and produced by Zorbiant.All rights reserved.   

RÆÆÆHHHH! I dagens episode snakker Eivind, Julia og Sara om Julias fucka hangover, som hun pådro seg i et 60-årslag. Vi snakker om "FUCK-YOU-TID" som man får etter eksamen og (som nevnt i tittelen) så fette dreper vi Oslos boligmarked. På tampen er Julia jævlig flau. Takk til Ima på teknikk.

„Plan je bio da imamo troje dece, ali sad ih je šestoro, okolnosti su se menjale, pa smo i posle petog deteta, pre dve godine, poželeli opet jednu bebu“, priča u novoj epizodi Mamazjanije Milena Kostić, poznata kao „Mama iz magareće klupe“, u čijoj kući, sa tri devojčice i tri dečaka, uzrasta od dve do 15 godina, nikad nije dosadno. Iako većina mama ne može da zamisli dan bez multitaskinga, Milena smatra da ako radimo više stvari istovremeno, na kraju ništa ne završimo kako treba. „Dugo sam praktikovala multitaskovanje jer deluje kao jedina opcija kad imate više dece, ali sad postavim prioritete, pa jedno po jedno. Ima dana koji deluju da traju 48 sati, a opet ima i onih koji se lakše podnose“, priča ova dobro organizovana mama. U kući sa šestoro dece uvek je izazovno i nema vremena za dosadu. „Imamo stariju, srednju i malu decu. Jedno dete, najstarija ćerka, sprema se za srednju školu, najmlađi sin je u jaslicama, jedan se priprema sad za prvi razred, a jedno dete za peti. Ovo je za nas vrlo tranzitni period. Škola nam je veoma važna, pa često vikendom suprug i ja sednemo sa njima da radimo bekap, tačnije sve ono što možda u školi propuste ili što im nije rečeno, nadoknade sa nama“, objašnjava Milena.

Never miss another webinar. Sign up here: https://imahealth.org/weekly-webinars/ Learn more: https://imahealth.org/cancer-research-innovationCancer diagnoses continue to rise—affecting younger people more than ever before. This week, join IMA Chief Scientific Officer Dr. Paul Marik and IMA Senior Fellow Dr. Mollie James for a timely webinar focused on cancer, recurrence, and the research helping to make sense of this troubling trend.Dr. Marik will present curated findings from the latest cancer research, while Dr. James brings firsthand clinical insight from the frontlines—together offering a powerful look at how science and real-world experience are shaping new guidance for patients and providers. With growing concern that the mRNA vaccine rollout may be contributing to the surge in cases and relapses, this discussion couldn't be more urgent.This conversation is central to IMA's commitment to addressing chronic disease and builds on the research curated in Dr. Marik's comprehensive Cancer Care guide:- Available free to DL: https://imahealth.org/research/cancer-care/ - Or to purchase: https://a.co/d/9QT8zKH• Donate: https://imahealth.org/donate/• Follow: https://imahealth.org/contact/• Webinar: https://imahealth.org/category/weekly-webinars/• Treatment: https://imahealth.org/treatment-protocols/• Medical Disclaimer: https://imahealth.org/about/terms-and-conditions/About IMA (Formerly FLCCC Alliance)The Independent Medical Alliance™ is a nonprofit, 501(c)(3) organization and coalition of physicians, nurses, and healthcare professionals united by a mission to restore trust and transparency in healthcare. The organization's mission is one driven by Honest Medicine™ that prioritizes patients above profits and emphasizes long-term wellness and disease prevention through empowerment of both physicians and their patients. With a focus on evidence-based medicine, informed consent, and systemic reform, IMA is driving a movement to create a more compassionate and effective healthcare system.For more information about the Independent Medical Alliance, visit www.IMAhealth.org

Após a identificação de um caso de gripe aviária em animal silvestre no município de Mateus Leme, o Governo de Minas concedeu uma entrevista coletiva para detalhar as medidas de prevenção à doença em todo o estado. Estiveram presentes representantes da Secretaria de Estado de Agricultura e Pecuária (Seapa) e do Instituto Mineiro de Agropecuária (IMA).

I dagens episode er det fyr og flamme stemning i studio!! Tuva, Andreas og Sara skravler om at the main momager har fått et nytt fjes, serien Overcompensation, sommerkrim, Ben and Jerrys som lager fire is og aktivisme og den internasjonale mensensdagen!!! Takk til Ima på teknikk!

Takozvana veštačka inteligencija nam je gotovo svuda od koristi. Da li je tako i u oblasti psihičkog zdravlja? Na tragu tog pitanja su danas Saša Bojić i Maja Marić. Već u prvim trenucima korišćenja automata za razgovor kao što je ChatGPT mnogi su pomislili da bi mogli da ih koriste i za psihoterapiju. Ima li to smisla? Sta AI savetuje doseljenicima u Nemačkoj? "Ako želiš, možemo i odmah da pričamo o tome što te muči." Molim? Stvarno? Pa nama onda u Nemačkoj ne treba više nikakva druga pomoć? Von Sasa Bojic.

Vit-on actuellement un tournant en matière de souveraineté numérique ?Cette semaine, Alain ne revient pas sur une, mais bien 3 actualités, qui révèlent les tensions croissantes autour de la souveraineté en France.

O Instituto Mineiro de Agropecuária (IMA) atualizou as normas de inspeção e fiscalização de produtos de origem animal previstas no decreto nº 49.030/2025, além de incorporar novas ferramentas digitais para otimizar o atendimento ao produtor mineiro. “O decreto, que atualiza legislação antiga, incorpora tecnologias modernas e reduz exigências, sem abrir mão das normas higiênico-sanitárias e das boas práticas de fabricação”, afirma Rômulo Lage, gerente de Inspeção de Produtos de Origem Animal do IMA.

I dag har Anja og Astrid gått inn i musikkverden for å diskutere Damiano David sin nye pop era, og Reneé Rapp sin nye sang. Veganisme som livssyn har blitt avslått av den norske stat og dette må så klart bli snakket om. De har også planlagt at denne sommeren skal fokuset være på interiør og å dyrke sine hobbyer!Takk til Ima på teknikk!

V tem mesecu se v Sloveniji spominjamo največjega genocida v zgodovini slovenskega naroda. Predsednica republike Nataša Pirc Musar se bo na povabilo ministra za obrambo Boruta Sajovica, teden dni pred tradicionalno slovesnostjo v Kočevskem rogu, udeležila spominske slovesnosti, kjer se bo poklonila žrtvam na kraju spomina Jama pod Macesnovo gorico.Vse bolj jasno je, da želi biti predsednica države Nataša Pirc Musar prvorazredna – a ne prvorazredna za vse, temveč samo za izbrane, tiste, ki so po njeni meri. Svojo vključevalnost si razlaga kot ekskluzivni klub ideološko všečnih, v katerega ne sodi vsak državljan, ampak le tisti, ki poklekne pred njenimi vrednotami.Gremo lepo po vrsti. Predsednica, ki ji letos mandat vstopa v drugo polovico, se šele zdaj očitno zaveda, da ji voda teče v grlo, če ne želi končati mandata kot Danilo Türk, ki je delil državljane na prvo in drugo razredne. Do danes se Nataša Pirc Musar še ni zmogla, kot prva med državljani, pokloniti žrtvam komunizma. Ima polna usta obsodb fašizma, nacizma, Srebrenice in zdaj Gaze, a največjega povojnega genocida na Slovenskem – množičnih pobojev pred in v letu 1945 – se izogiba kot maček vode.Mirno sedi z ideološkimi dediči krvnikov, jim podeljuje državna odlikovanja v imenu vseh državljanov – tudi tistih, katerih sorodniki so bili brez sodbe pobiti. Organizacijam, kot sta Nova slovenska zaveza in Združeni ob Lipi sprave, ki si leta prizadevajo za resnično, enakovredno in celostno spravo, pa obrne hrbet. Ne, ona gre raje po svoje. Po poti samovoljnosti in selektivnega spomina.S svojim ravnanjem postaja predsednica, ki je s par zamahi – kot slon v trgovini s porcelanom – uničila dolgoletna prizadevanja njenega predhodnika Boruta Pahorja za spravo. Skupaj z vlado je, tudi za ceno obiska pri pokojnem papežu Frančišku izsilila »začasni pokop« žrtev iz Macesnove gorice, ne da bi prisluhnila željam tistih, ki si prizadevajo za njihov dostojen pokop v slovenski prestolnici.Na naše vprašanje ali se bo udeležila slovenski v Kočevskem Rogu, ki jo 7. junija pripravlja Nova Slovenska zaveza so med drugim odgovorili, da je že ob začetku letošnjega leta potrdila udeležbo na 80. obletnici osvoboditve koncentracijskega taborišča Ljubelj, ki bo na isti dan ob 10. uri in kjer bo tudi slavnostna govornica. Zato je nemogoče, da bi se udeležila obeh. Ob tem pa ni pokazala niti kančka želje, da bi si prizadevala, da bi bila ena ali druga slovesnost malo prilagojena, da bi se lahko udeležila obeh slovesnosti. Zanimiv je tudi izgovor: kajti že več desetletij je slovesnost v Kočevskem Rogu postavljena v ta čas.Njeno govorjenje o spravi je tako kot ogledalo, ki odseva samo njen obraz – ne pa obraze vseh Slovencev. Sramotno. Žalostno. In predvsem – globoko ponižujoče do vseh, ki so zaradi komunizma izgubili življenje, dostojanstvo ali resnico, prav tako pa ponižujoče tudi do vseh, ki si iskreno prizadevajo za spravo med Slovenci. Predsednica, ki ima polna usta pravičnosti, a ne zmore niti enega iskrenega stavka obsodbe komunističnih zločinov, ne združuje – temveč razdvaja. In to ne z močjo resnice, ampak s silo selektivnega spomina.Da je mera polna pa vidimo tudi pri njenem nedržavotvornem delu, ko že nekaj časa blokira delovanje demokratičnih institucij. Do danes še ni našla primernega in za dvotretjinsko večino sprejemljivega kandidata ali kandidatke za varuha človekovih pravic. Če so v njen ožji izbor izmed 14-ih prijavljenih kandidatov prišli zgolj trije, o ostalih sploh ni pojasnila, zakaj jih ne predlaga – med temi so tudi ugleda imena kot sta denimo nevrolog dr. Zvezdan Pirtovšek in nekdanja varuhinja človekovih pravic Vlasta Nussdorfer, pa sedaj želi na to mesto kandidatko, ki se sploh ni prijavila za to mesto. Nekako se vse bolj izrisuje, da si pač želi na tem mestu nekoga, ki bo delal zgolj njej po všeči.Neuspešna je tudi pri kandidaturi za guvernerja Banke Slovenije. Naša država je tako v Evropski centralni banki brez glasovalnih pravic in to v času, ko se evropska unija sooča s poslabšano finančno sliko, naše države pa pri ukrepih ni zraven. Žalostno.Kaj kmalu pa bo jasno, koga bo izbrala na kmalu izpraznjena mesta ustavnih sodnikov. Dve imeni bo morala ponuditi. Bo tokrat bolj taktna ali pa bo tudi tukaj ustavnemu sodišču pomagala s še bolj ideološko skrajno levimi kandidati in tako pomagala pri razgradnji pravne države? Mislim, da sem naštel kar nekaj zadev, ki jasno kažejo, da predsednica ni kos nalogi, ki bi jo morala opravljati. Ne povezuje, si za povezovanje ne prizadeva, še več, namesto dialoga vnaša razdor, namesto sprave dodatne delitve. Bi bil čas, da bi odstopila ali pa morebiti sklicala predsedničin forum na temo svojega vladanja? Na to si odgovorite sami!

Tu veux créer ton entreprise mais tu es encore salariée ? Et si tu n'étais pas obligée de choisir ?➡️ Découvre l'outil Cli3nts pour prospecter à ta place sur Linkedin.Dans cet épisode, Sarah Zitouni prouve qu'on peut réussir en étant salariée ET entrepreneure.Fondatrice de PowHer ta carrière et directrice stratégie dans l'automobile, elle t'explique comment mener une double vie professionnelle sans perdre la tête… ni ton équilibre.

Blaž Strle je izkušen tehnološki vodja, ki zelo dobra razume in pozna disruptivne tehnologije, trende in inovacije in je Predsednik Uprave BE-terna Skupine, vodilnega evropskega ponudnika informacijskih rešitev. Svojo pot je začel kot poslovni svetovalec in vztrajno napredoval po lestvici, kjer je vodil ekipe v Adacti, postal izvršni direktor Adacta Dynamics,  nato postal COO BE-terna Skupine in na koncu stopil v vlogo Predsednika Uprave. Njegova pot znotraj podjetja je dokaz, kaj je mogoče s predanostjo in vztrajnostjo. Blaževa zgodba, ki prihaja iz Slovenije, dokazuje, da s trdim delom uspeh ne pozna meja. Ima diplomo iz računalništva in MBA, ki ga je pridobil na prestižni šoli v Španiji, IE Business School.

Never miss another webinar. Sign up here: https://imahealth.org/weekly-webinars/ Learn more: https://imahealth.org/hhs-mrna-children-pregnancy-whats-next/What happens when government agencies start to reverse course on the most hotly debated public health policies of our time?Join host Dr. Chris Martenson for a powerful conversation on the future of COVID-19 vaccine policy. He's joined by former Deputy Assistant Secretary of HHS David Mansdoerfer and three special guests—Senator Ron Johnson, IMA Senior Fellow Dr. Jordan Vaughn, and attorney Warner Mendenhall of Freedom Counsel—for a timely breakdown of the May 21, 2025, U.S. Senate hearing on COVID-19 vaccine development and safety.With HHS now considering the removal of COVID-19 shots from the CDC's recommended schedule for children and pregnant women, we could see a dramatic reshaping of the legal, medical, and political landscape. Our panel will explore what this move could mean for liability protections under the PREP Act, vaccine policy, public trust, and the future of informed consent.Momentum around mRNA vaccine reform is building. Last week, we launched our Smart Moms Ask campaign to end recommendations for children and pregnant women—and now federal agencies are beginning to reconsider vaccine policy. At the heart of this shift is one of IMA's core pillars for healthcare reform: Transparency in Medicine. It's not just a guiding principle—it's a catalyst for change. Don't miss this critical conversation about what comes next.URL: https://imahealth.org/hhs-mrna-children-pregnancy-whats-next/Keywords/Tags: mRNA in children, mRNA vaccine in pregnancy• Donate: https://imahealth.org/donate/• Follow: https://imahealth.org/contact/• Webinar: https://imahealth.org/category/weekly-webinars/• Treatment: https://imahealth.org/treatment-protocols/• Medical Disclaimer: https://imahealth.org/about/terms-and-conditions/About IMA (Formerly FLCCC Alliance)The Independent Medical Alliance™ is a nonprofit, 501(c)(3) organization and coalition of physicians, nurses, and healthcare professionals united by a mission to restore trust and transparency in healthcare. The organization's mission is one driven by Honest Medicine™ that prioritizes patients above profits and emphasizes long-term wellness and disease prevention through empowerment of both physicians and their patients. With a focus on evidence-based medicine, informed consent, and systemic reform, IMA is driving a movement to create a more compassionate and effective healthcare system.For more information about the Independent Medical Alliance, visit www.IMAhealth.org

In our conversation, we look at the busy workload of both client-side Insight teams and market research agencies, and the empathy that the best of each demonstrate for the other. This includes the well-being of all concerned in the research process, and steps we can all take to help each other.Central to the discussion is AURA's Working Well Together charter, which has been designed to foster healthier, thriving collaborations. Ruth talks about the 6 principles enshrined within the charter, and James E. gives his perspective on the principles that agencies think most important and those that he would like us to prioritise.Do agencies receive all the information that they would like when making proposals for new projects? Do Insight teams themselves always know the full commercial and strategic context surrounding the business issues? How can we take time to share feedback at key moments in the research process?We couldn't finish our conversation, looking ahead. Will generative AI prompt changes in the mix between agency work and in-house research? And how can we all place the emphasis on building great relationships that James and Ruth both see as so critical? Please listen to find out more! Topics DiscussedStrengthening client-agency partnerships in Insight teams (02:46)Importance of agency collaboration in projects (11:50) Maximising stakeholder involvement for Insight (17:01) Future of client-agency partnerships and AI (24:51) The development of corporate and agency Insight teams (28:02)  Highlights“The topic of wellbeing and mental health more broadly in the UK sector: research that was done by the MRS a few years ago showed that there are high levels of poor mental health and examples of stress and a lot of that comes from the interface between clients and agencies.” (04:12)“Over time, as that relationship grows and you get to know their business better, that just becomes even easier and easier and easier, and you know so much more anyway. But it really is essential to give as much information as possible.” (15.34)“In AURA's webinar about procurement, we had an expert who specialises in marketing services who absolutely acknowledges that research is not widgets and you can't put out a request for proposals and assess it in the same way in which you could assess buying something physical for your business or buying a commodity for your business.” (22.35)“We do all need to be mindful of training needs for our people on both sides. Training needs, perhaps on the client-side, of communication and championing insights inside the organisation, so that those conversations are very easy to get the briefs that we've been talking about, because all the stakeholders are fully aware of what's needed and what's required and how important it is.” (28.02) This is episode 71 of the Transforming Insight podcast. If you have the ambition to transform your Insight team and the role it plays in your organisation, please tune in to future episodes. Not only will we explore the secrets of successful corporate Insight teams and their leaders, as outlined in James Wycherley's books, Transforming Insight and The Insight Leader's Playbook, we will also talk to senior corporate Insight leaders, delve into books that have inspired us, and discuss new best practice research carried out with the IMA's corporate members.You won't want to miss this! So please subscribe - and thank you for listening.  About James Wycherley, the author of Transforming InsightJames Wycherley was Director of Customer Insight and Analytics at Barclays Bank from 2005 to 2015 when he became Chief Executive of the Insight Management Academy (IMA). He published his first book, Transforming Insight, in 2020, and his second, The Insight Leader's Playbook, in 2025, and he hosts the Insight forums and the Transforming Insight podcast.An entertaining keynote speaker, he has presented over 50 times at Quirk's events, a global record, and has provided thought leadership in the UK, USA, Europe, Canada, Australia, India and the Middle East.The Insight Management Academy is the world's leading authority on transforming corporate Insight teams, and its vision is to inspire and support every Insight leader to transform the impact of Insight in their organisation. Resources:If you would like more information on any of the ideas discussed in this episode of the Transforming Insight podcast, please visit www.insight-management.org DisclaimerThe Transforming Insight podcast is published by the Insight Management Academy and produced by Zorbiant.All rights reserved.   

Tu veux créer ton entreprise mais tu es encore salariée ? Et si tu n'étais pas obligée de choisir ?Dans cet épisode, Sarah Zitouni prouve qu'on peut réussir en étant salariée ET entrepreneure.Fondatrice de PowHer ta carrière et directrice stratégie dans l'automobile, elle t'explique comment mener une double vie professionnelle sans perdre la tête… ni ton équilibre.

Blaž Strle je izkušen tehnološki vodja, ki zelo dobra razume in pozna disruptivne tehnologije, trende in inovacije in je Predsednik Uprave BE-terna Skupine, vodilnega evropskega ponudnika informacijskih rešitev. Svojo pot je začel kot poslovni svetovalec in vztrajno napredoval po lestvici, kjer je vodil ekipe v Adacti, postal izvršni direktor Adacta Dynamics,  nato postal COO BE-terna Skupine in na koncu stopil v vlogo Predsednika Uprave. Njegova pot znotraj podjetja je dokaz, kaj je mogoče s predanostjo in vztrajnostjo. Blaževa zgodba, ki prihaja iz Slovenije, dokazuje, da s trdim delom uspeh ne pozna meja. Ima diplomo iz računalništva in MBA, ki ga je pridobil na prestižni šoli v Španiji, IE Business School. Blaž Strle med tremi dejavniki uspeha družbe BE-terna izpostavlja znanje, inovativnost in usmerjenost v uspeh svojih strank. Največjo poslovno lekcijo pa opisuje tako: »Najpomembnejša je ekipa, vse ostalo je drugotnega pomena.« Postaviti prave ljudi na pravo mesto in vzpostaviti dobro okolje je največ, kar lahko vodja naredi. Kot vodja ne verjame v stereotipe in en »Leadership style«. Pristopa ne moreš ukalupiti, podjetje se razvija, situacije so različne, različni so ljudje…, učiš se in prilagajaš. Včasih ne smeš dati več kot le ključe, drugič cilje, tretjič »korenček«, naslednjič »palico«, včasih je ventil treba priviti, drugič sprostiti. Vse s ciljem, da bomo jutri boljši, kot smo danes. Blaž je prepričan, da mora biti dober vodja v prvi vrsti »dober človek«, ki zna prisluhniti, biti dostopen, voditi z zgledom in navduševati. Za odličnost vodenja je pomembno dati v ospredje podjetje in zaposlene, povedati, kar misliš, verjeti v to, kar govoriš, in stati za svojimi dejanji. Prvi del se preslika v zaupanje, drugi pa v navduševanje. Je zahteven, saj od sebe in od sodelavcev pričakuje nadpovprečnost in učinkovitost. Najljubši citat: The problem is not the problem, the problem is your attitude about the problem. Najljubša knjiga: Good to GreatNajljubša serija: M*A*S*HHobiji: potovanja, jadranje, šport, dirkanjeNajljubša hrana: sushiNajljubši podjetnik: Warren BuffettNajljubša aplikacija: InstagramZaključni nauki za naše poslušalce:·      Sreča je bolj odvisna od nas samih, kot od okolice. Kroti žival v sebi in boš srečen.·      Bodi takšen kot želiš. da bi bili drugi do tebe.·      Male spremembe delajo velike razlike.

Outline00:00 - Intro and early steps in control06:42 - Journey to the US08:30 - Kharitonov's theorem and early influences12:10 - From Lund to KTH (Stockholm)15:01 - Ascona and collaboration with Megretski24:06 - The IMA year in Minnesota33:50 - Integral quadratic constraints46:10 - KYP lemma and meeting Yakubovich52:35 - Piecewise hybrid systems59:41 - Dual to Lyapunov theorem1:06:48 -  Positivity and large scale systems1:15:25 - Adaptive and dual control1:25:24 - Future research directionsLinks Master's thesis: https://tinyurl.com/vnkuf44a Kharitonov's theorem: https://tinyurl.com/3w3a3z52IMA: https://cse.umn.edu/imaLCCC: http://www.lccc.lth.se/Real stability radius paper: https://tinyurl.com/yc79zt58IQC paper: https://tinyurl.com/mw2te4vwKYP lemma paper: https://tinyurl.com/2fv32yw6Piecewise quadratic Lyapunov functions for hybrid systems: https://tinyurl.com/38a5f432Piecewise linear quadratic optimal control: https://tinyurl.com/yhddbhpxFast switches in relay feedback systems: https://tinyurl.com/23e95k9nDual to Lyapunov's stability theorem: https://tinyurl.com/yc2uf652ECC'15 plenary: https://tinyurl.com/sy3k7vf7Scalable control of positive systems: https://tinyurl.com/3vcda447Tutorial on Positive Systems and Large Scale Control: https://tinyurl.com/3e4fkxz8KYP lemma for positive systems: https://tinyurl.com/3pdp3p7pCDC'25 plenary: https://tinyurl.com/497py5whData driven Riccati equation: https://tinyurl.com/3swjtvabSupport the showPodcast infoPodcast website: https://www.incontrolpodcast.com/Apple Podcasts: https://tinyurl.com/5n84j85jSpotify: https://tinyurl.com/4rwztj3cRSS: https://tinyurl.com/yc2fcv4yYoutube: https://tinyurl.com/bdbvhsj6Facebook: https://tinyurl.com/3z24yr43Twitter: https://twitter.com/IncontrolPInstagram: https://tinyurl.com/35cu4kr4Acknowledgments and sponsorsThis episode was supported by the National Centre of Competence in Research on «Dependable, ubiquitous automation» and the IFAC Activity fund. The podcast benefits from the help of an incredibly talented and passionate team. Special thanks to L. Seward, E. Cahard, F. Banis, F. Dörfler, J. Lygeros, ETH studio and mirrorlake . Music was composed by A New Element.

Símbolos da identidade gastronômica de Minas Gerais e Patrimônio Cultural Imaterial Brasileiro (IPHAN, 2008), os queijos artesanais acabam de ganhar uma atualização em sua legislação. Trata-se da Portaria 2373 do Instituto Mineiro de Agropecuária (IMA), que estabelece algumas regras que devem ser seguidas durante os processos de fabricação dos chamados "queijos artesanais autorais”.

Never miss another webinar. Sign up here: https://imahealth.org/weekly-webinars/ Learn more: https://imahealth.org/autism-vaccines-forbidden-conversation/Dr. Andy Wakefield has spent decades at the center of one of the most controversial topics in modern medicine: vaccines and their potential link to autism. This week, IMA Co-Founder and Chief Scientific Officer Dr. Paul Marik welcomes Wakefield for a timely conversation about his early research, the backlash that followed, and how his voice continues to resonate in today's medical climate. They'll also explore Protocol 7, Wakefield's new award-winning film that marks his transition from researcher to filmmaker.With HHS now promising its first-ever placebo-controlled trials for childhood vaccines, and RFK Jr. pledging to release long-suppressed vaccine safety data, Wakefield's early warnings are taking on renewed urgency. This is more than a debate—it's a reminder of why transparency in medicine is one of IMA's core pillars, and why honest conversations like this one matter more than ever.Keywords/Tags: autism vaccines• Donate: https://imahealth.org/donate/• Follow: https://imahealth.org/contact/• Webinar: https://imahealth.org/category/weekly-webinars/• Treatment: https://imahealth.org/treatment-protocols/• Medical Disclaimer: https://imahealth.org/about/terms-and-conditions/About IMA (Formerly FLCCC Alliance)The Independent Medical Alliance™ is a nonprofit, 501(c)(3) organization and coalition of physicians, nurses, and healthcare professionals united by a mission to restore trust and transparency in healthcare. The organization's mission is one driven by Honest Medicine™ that prioritizes patients above profits and emphasizes long-term wellness and disease prevention through empowerment of both physicians and their patients. With a focus on evidence-based medicine, informed consent, and systemic reform, IMA is driving a movement to create a more compassionate and effective healthcare system.For more information about the Independent Medical Alliance, visit www.IMAhealth.org

Never miss another webinar. Sign up here: https://imahealth.org/weekly-webinars/On our website: https://imahealth.org/stop-the-mrna-shotsWhat happens when moms ask hard questions—and get ignored? With rising concerns over COVID-19 mRNA vaccine risks, a growing movement is demanding real answers. This week's webinar launches “Smart Moms Ask,” a new IMA-led campaign empowering mothers to advocate for true informed consent—especially when it comes to protecting children and pregnant women.Join host Dr. Chris Martenson and IMA Senior Fellows Dr. Kat Lindley, Dr. Ryan Cole, Dr. Liz Mumper, and Dr. Kim Biss for a vital conversation on vaccine safety, maternal health, and why the science demands we halt mRNA shots for our most vulnerable. From increased miscarriage and myocarditis rates to fertility concerns and negative efficacy data, the evidence is clear—and it cannot be ignored any longer.• Donate: https://imahealth.org/donate/• Follow: https://imahealth.org/contact/• Webinar: https://imahealth.org/category/weekly-webinars/• Treatment: https://imahealth.org/treatment-protocols/• Medical Disclaimer: https://imahealth.org/about/terms-and-conditions/About IMA (Formerly FLCCC Alliance)The Independent Medical Alliance™ is a nonprofit, 501(c)(3) organization and coalition of physicians, nurses, and healthcare professionals united by a mission to restore trust and transparency in healthcare. The organization's mission is one driven by Honest Medicine™ that prioritizes patients above profits and emphasizes long-term wellness and disease prevention through empowerment of both physicians and their patients. With a focus on evidence-based medicine, informed consent, and systemic reform, IMA is driving a movement to create a more compassionate and effective healthcare system.For more information about the Independent Medical Alliance, visit www.IMAhealth.org

James is joined by IMA Senior Insight Adviser, Roy Hammond, who developed a more strategic approach to managing agency relationships at Barclays.In this week's episode:We can't just rely on the people we manage (1.30)Don't forget internal departments (3.06)Roy Hammond's approach to the strategic management of agencies (8.46)We're never trained in how to manage partnerships (11.27)How do we measure agency performance? (14.17)The attributes of great partnerships (18.12) Please listen to find out more! This is episode 70 of the Transforming Insight podcast. If you have the ambition to transform your Insight team and the role it plays in your organisation, please tune in to future episodes. Not only will we explore the secrets of successful corporate Insight teams and their leaders, as outlined in James Wycherley's books, Transforming Insight and The Insight Leader's Playbook, we will also talk to senior corporate Insight leaders, delve into books that have inspired us, and discuss new best practice research carried out with the IMA's corporate members.You won't want to miss this! So please subscribe - and thank you for listening.  About James Wycherley, the author of Transforming InsightJames Wycherley was Director of Customer Insight and Analytics at Barclays Bank from 2005 to 2015 when he became Chief Executive of the Insight Management Academy (IMA). He published his first book, Transforming Insight, in 2020, and his second, The Insight Leader's Playbook, in 2025, and he hosts the Insight forums and the Transforming Insight podcast.An entertaining keynote speaker, he has presented over 50 times at Quirk's events, a global record, and has provided thought leadership in the UK, USA, Europe, Canada, Australia, India and the Middle East.The Insight Management Academy is the world's leading authority on transforming corporate Insight teams, and its vision is to inspire and support every Insight leader to transform the impact of Insight in their organisation. Resources:If you would like more information on any of the ideas discussed in this episode of the Transforming Insight podcast, please visit www.insight-management.org DisclaimerThe Transforming Insight podcast is published by the Insight Management Academy and produced by Zorbiant.All rights reserved.   

Morgan Stanley Research analyst Mark Schmidt and Investment Management's Craig Brandon discuss the heightened uncertainty in the U.S. municipal bonds market.Read more insights from Morgan Stanley.For a full list of episode disclosures click here.----- Transcript -----Mark Schmidt: Welcome to Thoughts on the Market. I'm Mark Schmidt, Morgan Stanley's Head of Municipal Strategy.Craig Brandon: I'm Craig Brandon, Co-Director of Municipal Investments at Morgan Stanley Investment Management.Mark Schmidt: Today, let's talk about the biggest market you hardly ever hear about – municipal bonds, a $4 trillion asset class.It's Monday, May 5th at 10am in Boston.Mark Schmidt: If you've driven, flown, gone to school or turned on a tap, chances are munis made it happen. Although munis are late cycle haven, they were not immune to the latest bout of market volatility. Craig, why was April so tough?Craig Brandon: So, what we say in April, it was sort of the trifecta of things that happened that were a little different than other asset classes. The first thing that happened is we saw a significant increase in treasury rates – and munis are generally correlated to treasuries. We're a very high-quality asset class, that's viewed as a duration asset class. So, one thing we saw were rates going up. When we see rates going up, you generally see money coming out of the market, right? So, I think investors were a little bit impacted by the higher rates, the correlation to treasuries, the duration, and saw some flows out of the market.Secondly, what we saw is conversation about the tax exemption in Washington D.C. What that did is it caused muni issuers to pull their issuance forward. So, if you're an infrastructure issuer, you are issuing bonds in the next year to year and a half; you're going to pull that forward because if there's any risk of loss of the tax exemption, you want to get these bonds issued today. So that's basically what drives technicals. It's supply and demand. So, what we saw was a decrease in demand because of higher rates; an increase in supply because of issuance being pulled forward.And the third part of the trifecta we refer to is the conversations about the economy. So, I would put that, it's sort of a distant third, but there's still conversations about maybe credit weakness driven by a slowing economy.Mark Schmidt: Craig, your team has been through a lot of tough market cycles. Given your experience, how did the most recent selloff compare? And why was it not like 2008?Craig Brandon: I started my career back in 1998 during the long-term capital management crisis. I lived through 2008. I lived through the COVID crisis, and you know, really when I look at the crisis in 2008 – no banks went out of business three weeks ago, right? In 2008 we were really sitting on a trading desk wondering where this was going to end.You know, we had a number of meetings with our staff, over the last couple weeks explaining to them why it was different and how. Yes, there was some volatility here, but you could see that there was going to be an end to this, and this was not going to be a permanent restructuring of the market. So, I think we felt comfortable. It was very different than 2008 and it really felt different than COVID.Mark Schmidt: That's reassuring. But with economic growth set to slow sharply, how does your credit team think the fiscal health of America's state and local governments will hold up?Craig Brandon: Well, remember state and local governments, and when we're talking about munis, we're also talking about other infrastructure asset classes like water and sewer bonds. Like, you know, transportation, bonds, airports. We're talking about toll roads.They went into this with a very strong balance sheet, right? Remember, there was a lot of infrastructure money spent by the federal government during COVID to give issuers money to make it through COVID. There's still a lot of money on balance sheets. So, what we do is we're going into this crisis with a lot of cash on balance sheets, allowing issuers to be able to withstand some weakness in the economy and get through to the other side of this.Mark Schmidt: Not only do state and local governments have a lot of cash, but they're just not that impacted by tariffs, right? So why did muni yields perform worse than U.S. treasuries over the past couple of weeks?Craig Brandon: Right. It really… We're technically driven, right? The U.S. muni market is more retail driven than some other asset classes. Remember – investment grade corporates, treasury bonds, there's a lot of institutional buyers in those markets. In the municipal market, it's primarily retail driven.So, when you know, individual retail investors get nervous, they tend to pull money out of the market. So, what we saw was money coming out of the market. At the same time, we saw an individual increase in more bonds, which just led to very weak technicals, which when we see that it eventually reverses itself.Mark Schmidt: Now I almost buried the lede, right? Why invest in munis? Well, they're great credit quality, but they're also tax free. In fact, muni bonds have been exempt from federal taxes for over a century. You have a lot of experience putting together tax bills, and right now people are worried about tax reform. Do you think investors should be concerned?Craig Brandon: Listen. I'm not really losing a lot of sleep at night over the tax exemption. And I think there's other, you know, issues to worry about. Why do I say that?As you mentioned Mark, I spent the early years of my career working for the New York State Assembly Ways and Means Committee. I spent seven years negotiating budgets and what that did is it gave me a window – into how, you know, not only state budgets, but the federal budget gets put together.So, what it also showed me was the relationship between state and local elected officials and your representatives in Congress and your representatives in the Senate. So, I know firsthand that members of Congress and members of the Senate in Washington have very close relationships with members of the state legislatures, with governors, with mayors, with city council members, with school board members – who are all delivering the message that significantly higher financing costs that could potentially happen from the loss of the exemption, could be meaningful to them.And I think members of Congress and members of the Senate and Washington get it. They understand it because they were all there when it happened. The last time the muni exemption came under fire was back in 2012; and in 2012, a lot of members of Congress were in the state legislature back then, so they understand it.Mark Schmidt: That's reassuring because right now, tax equivalent yields in the muni market are 7 to 8 per cent. That's equal to or greater than the long run rate of return on the stock market. So, whether to invest in the muni market seems pretty straightforward. How to invest in the muni market? Well, with 50,000 issuers, that's a little complicated. How do you recommend investors get exposure to tax-free munis right now?Craig Brandon: Well, and that is a very common question. The muni market can be very confusing because there are just so many bonds out there. You know, over 50,000 issuers, there's over a million individual CUSIPs in the muni market.So as an individual investor, where do you start? There's different coupon structures, different call structures, different maturity structures, ratings. There's so many different variables that go into a decision in investing in muni bonds.I can make an argument that you could probably mimic the S&P 500 with 500 different stocks. But most muni indices are over 50,000 constituents. It's very difficult to replicate the muni market by yourself, which is why a lot of people, you know, they let professional money managers, do the investing for them. Whether you're looking at mutual funds, whether you're looking at separately managed accounts, whether you're looking at exchange traded fund ETFs, there's a lot of different ways to get exposure to the muni market. But with the huge amount of choices you have to make, I think a lot of individual investors would just let a professional with the experience do it.Mark Schmidt: And active managers let you customize portfolios to your unique tax situation and risk tolerance. So, Craig, a final question for you. How do munis fit into a diversified portfolio?Craig Brandon: Munis are generally the stable part of most people's portfolios. Remember, you don't have a choice of whether you're going to pay your taxes or not. You have to pay your taxes, you have to pay your water bill, you have to pay your power bill. You have to pay tolls on highways. You have to pay airport fees when you buy an airline ticket, right?It's not an option. So, because the revenue streams are so stable, you see most muni bonds rated AA or AAA. The default rate for rated munis is significantly below 1 per cent. It's something in the ballpark of about 0.2 per cent*. So, with such a low default rate – listen, we're technically driven, as I said. You see ups and downs in the market. But over a longer period of time, munis can give you generally stable returns, tax exempt income over the long term, and they're one of the more stable asset classes that you see in your overall portfolio.Mark Schmidt: That sounds boring, and I mean that in the best possible way. Craig, thanks so much for your time today.Craig Brandon: Thanks, Mark, happy to be hereMark Schmidt: And thank you for listening. If you enjoy Thoughts on the Market, please leave us a review wherever you listen and share the podcast with a friend or colleague today.*“US Municipal Bond Defaults and Recoveries, 1970-2021” – Moody's Investor ServicesDisclosure: Past performance is no guarantee of future results. The returns referred to in the commentary are those of representative indices and are not meant to depict the performance of a specific investment.Risk ConsiderationsDiversification does not eliminate the risk of loss.There is no assurance that a portfolio will achieve its investment objective. Portfolios are subject to market risk, which is the possibility that the market values of securities owned by the portfolio will decline and that the value of portfolio shares may therefore be less than what you paid for them. Market values can change daily due to economic and other events (e.g., natural disasters, health crises, terrorism, conflicts, and social unrest) that affect markets, countries, companies or governments. It is difficult to predict the timing, duration, and potential adverse effects (e.g., portfolio liquidity) of events. Accordingly, you can lose money investing in a portfolio. Fixed-income securities are subject to the ability of an issuer to make timely principal and interest payments (credit risk), changes in interest rates (interest rate risk), the creditworthiness of the issuer and general market liquidity (market risk). In a rising interest-rate environment, bond prices may fall and may result in periods of volatility and increased portfolio redemptions. In a declining interest-rate environment, the portfolio may generate less income. Longer-term securities may be more sensitive to interest rate changes. An imbalance in supply and demand in the municipal market may result in valuation uncertainties and greater volatility, less liquidity, widening credit spreads and a lack of price transparency in the market. There generally is limited public information about municipal issuers. Income from tax-exempt municipal obligations could be declared taxable because of changes in tax laws, adverse interpretations by the relevant taxing authority or the non-compliant conduct of the issuer of an obligation and may subject to the federal alternative minimum tax.There is no guarantee that any investment strategy will work under all market conditions, and each investor should evaluate their ability to invest for the long-term, especially during periods of downturn in the market.A separately managed account may not be appropriate for all investors. Separate accounts managed according to the particular strategy may include securities that may not necessarily track the performance of a particular index. Please consider the investment objectives, risks and fees of the Strategy carefully before investing. A minimum asset level is required. For important information about the investment managers, please refer to Form ADV Part 2.The views and opinions and/or analysis expressed are those of the author or the investment team as of the date of preparation of this material and are subject to change at any time without notice due to market or economic conditions and may not necessarily come to pass.This material has been prepared on the basis of publicly available information, internally developed data and other third-party sources believed to be reliable. However, no assurances are provided regarding the reliability of such information and the Firm has not sought to independently verify information taken from public and third-party sources.This material is a general communication, which is not impartial and all information provided has been prepared solely for informational and educational purposes and does not constitute an offer or a recommendation to buy or sell any particular security or to adopt any specific investment strategy. The information herein has not been based on a consideration of any individual investor circumstances and is not investment advice, nor should it be construed in any way as tax, accounting, legal or regulatory advice. To that end, investors should seek independent legal and financial advice, including advice as to tax consequences, before making any investment decision.The Firm has not authorised financial intermediaries to use and to distribute this material, unless such use and distribution is made in accordance with applicable law and regulation. Additionally, financial intermediaries are required to satisfy themselves that the information in this material is appropriate for any person to whom they provide this material in view of that person's circumstances and purpose. The Firm shall not be liable for, and accepts no liability for, the use or misuse of this material by any such financial intermediary.This material may be translated into other languages. Where such a translation is made this English version remains definitive. If there are any discrepancies between the English version and any version of this material in another language, the English version shall prevail.The whole or any part of this material may not be directly or indirectly reproduced, copied, modified, used to create a derivative work, performed, displayed, published, posted, licensed, framed, distributed or transmitted or any of its contents disclosed to third parties without the Firm's express written consent. This material may not be linked to unless such hyperlink is for personal and non-commercial use. All information contained herein is proprietary and is protected under copyright and other applicable law.Eaton Vance is part of Morgan Stanley Investment Management. Morgan Stanley Investment Management is the asset management division of Morgan Stanley.DISTRIBUTIONThis material is only intended for and will only be distributed to persons resident in jurisdictions where such distribution or availability would not be contrary to local laws or regulations.MSIM, the asset management division of Morgan Stanley (NYSE: MS), and its affiliates have arrangements in place to market each other's products and services. Each MSIM affiliate is regulated as appropriate in the jurisdiction it operates. MSIM's affiliates are: Eaton Vance Management (International) Limited, Eaton Vance Advisers International Ltd, Calvert Research and Management, Eaton Vance Management, Parametric Portfolio Associates LLC and Atlanta Capital Management LLC.This material has been issued by any one or more of the following entities:EMEA:This material is for Professional Clients/Accredited Investors only.In the EU, MSIM and Eaton Vance materials are issued by MSIM Fund Management (Ireland) Limited (“FMIL”). FMIL is regulated by the Central Bank of Ireland and is incorporated in Ireland as a private company limited by shares with company registration number 616661 and has its registered address at 24-26 City Quay, Dublin 2, D02 NY 19, Ireland. Outside the EU, MSIM materials are issued by Morgan Stanley Investment Management Limited (MSIM Ltd) is authorised and regulated by the Financial Conduct Authority. Registered in England. Registered No. 1981121. Registered Office: 25 Cabot Square, Canary Wharf, London E14 4QA.In Switzerland, MSIM materials are issued by Morgan Stanley & Co. International plc, London (Zurich Branch) Authorised and regulated by the Eidgenössische Finanzmarktaufsicht ("FINMA"). Registered Office: Beethovenstrasse 33, 8002 Zurich, Switzerland.Outside the US and EU, Eaton Vance materials are issued by Eaton Vance Management (International) Limited (“EVMI”) 125 Old Broad Street, London, EC2N 1AR, UK, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority.Italy: MSIM FMIL (Milan Branch), (Sede Secondaria di Milano) Palazzo Serbelloni Corso Venezia, 16 20121 Milano, Italy. The Netherlands: MSIM FMIL (Amsterdam Branch), Rembrandt Tower, 11th Floor Amstelplein 1 1096HA, Netherlands. France: MSIM FMIL (Paris Branch), 61 rue de Monceau 75008 Paris, France. Spain: MSIM FMIL (Madrid Branch), Calle Serrano 55, 28006, Madrid, Spain. Germany: Germany: MSIM FMIL (Frankfurt Branch), Grosse Gallusstrasse 18, 60312 Frankfurt am Main, Germany (Gattung: Zweigniederlassung (FDI) gem. § 53b KWG). Denmark: MSIM FMIL (Copenhagen Branch), Gorrissen Federspiel, Axel Towers, Axeltorv2, 1609 Copenhagen V, Denmark.MIDDLE EASTDubai: MSIM Ltd (Representative Office, Unit Precinct 3-7th Floor-Unit 701 and 702, Level 7, Gate Precinct Building 3, Dubai International Financial Centre, Dubai, 506501, United Arab Emirates. Telephone: +97 (0)14 709 7158). This document is distributed in the Dubai International Financial Centre by Morgan Stanley Investment Management Limited (Representative Office), an entity regulated by the Dubai Financial Services Authority (“DFSA”). It is intended for use by professional clients and market counterparties only. This document is not intended for distribution to retail clients, and retail clients should not act upon the information contained in this document.This document relates to a financial product which is not subject to any form of regulation or approval by the DFSA. The DFSA has no responsibility for reviewing or verifying any documents in connection with this financial product. Accordingly, the DFSA has not approved this document or any other associated documents nor taken any steps to verify the information set out in this document, and has no responsibility for it. The financial product to which this document relates may be illiquid and/or subject to restrictions on its resale or transfer. Prospective purchasers should conduct their own due diligence on the financial product. If you do not understand the contents of this document, you should consult an authorised financial adviser.USNOT FDIC INSURED | OFFER NO BANK GUARANTEE | MAY LOSE VALUE | NOT INSURED BY ANY FEDERAL GOVERNMENT AGENCY | NOT A DEPOSITLatin America (Brazil, Chile Colombia, Mexico, Peru, and Uruguay)This material is for use with an institutional investor or a qualified investor only. All information contained herein is confidential and is for the exclusive use and review of the intended addressee, and may not be passed on to any third party. This material is provided for informational purposes only and does not constitute a public offering, solicitation or recommendation to buy or sell for any product, service, security and/or strategy. A decision to invest should only be made after reading the strategy documentation and conducting in-depth and independent due diligence.ASIA PACIFICHong Kong: This material is disseminated by Morgan Stanley Asia Limited for use in Hong Kong and shall only be made available to “professional investors” as defined under the Securities and Futures Ordinance of Hong Kong (Cap 571). The contents of this material have not been reviewed nor approved by any regulatory authority including the Securities and Futures Commission in Hong Kong. Accordingly, save where an exemption is available under the relevant law, this material shall not be issued, circulated, distributed, directed at, or made available to, the public in Hong Kong. Singapore: This material is disseminated by Morgan Stanley Investment Management Company and may not be circulated or distributed, whether directly or indirectly, to persons in Singapore other than to (i) an accredited investor (ii) an expert investor or (iii) an institutional investor as defined in Section 4A of the Securities and Futures Act, Chapter 289 of Singapore (“SFA”); or (iv) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA. This publication has not been reviewed by the Monetary Authority of Singapore. Australia: This material is provided by Morgan Stanley Investment Management (Australia) Pty Ltd ABN 22122040037, AFSL No. 314182 and its affiliates and does not constitute an offer of interests. Morgan Stanley Investment Management (Australia) Pty Limited arranges for MSIM affiliates to provide financial services to Australian wholesale clients. Interests will only be offered in circumstances under which no disclosure is required under the Corporations Act 2001 (Cth) (the “Corporations Act”). Any offer of interests will not purport to be an offer of interests in circumstances under which disclosure is required under the Corporations Act and will only be made to persons who qualify as a “wholesale client” (as defined in the Corporations Act). This material will not be lodged with the Australian Securities and Investments Commission.Japan:For professional investors, this document is circulated or distributed for informational purposes only. For those who are not professional investors, this document is provided in relation to Morgan Stanley Investment Management (Japan) Co., Ltd. (“MSIMJ”)'s business with respect to discretionary investment management agreements (“IMA”) and investment advisory agreements (“IAA”). This is not for the purpose of a recommendation or solicitation of transactions or offers any particular financial instruments. Under an IMA, with respect to management of assets of a client, the client prescribes basic management policies in advance and commissions MSIMJ to make all investment decisions based on an analysis of the value, etc. of the securities, and MSIMJ accepts such commission. The client shall delegate to MSIMJ the authorities necessary for making investment. MSIMJ exercises the delegated authorities based on investment decisions of MSIMJ, and the client shall not make individual instructions. All investment profits and losses belong to the clients; principal is not guaranteed. Please consider the investment objectives and nature of risks before investing. As an investment advisory fee for an IAA or an IMA, the amount of assets subject to the contract multiplied by a certain rate (the upper limit is 2.20% per annum (including tax)) shall be incurred in proportion to the contract period. For some strategies, a contingency fee may be incurred in addition to the fee mentioned above. Indirect charges also may be incurred, such as brokerage commissions for incorporated securities. Since these charges and expenses are different depending on a contract and other factors, MSIMJ cannot present the rates, upper limits, etc. in advance. All clients should read the Documents Provided Prior to the Conclusion of a Contract carefully before executing an agreement. This document is disseminated in Japan by MSIMJ, Registered No. 410 (Director of Kanto Local Finance Bureau (Financial Instruments Firms)), Membership: The Japan Securities Dealers Association, the Investment Trusts Association, Japan, the Japan Investment Advisers Association and the Type II Financial Instruments Firms Association.© 2025 Morgan Stanley. All rights reserved. 4459984 Exp. 19/02/2026

Investicija od 600.000€ - ekskluzivna priča o povjerenju, pregovorima i AI-u. Ima li uistinu ravnopravnosti kada se jedni nasuprot drugih nađu osnivač čiji je projekt tek u povojima i investitori koji potencijalno drže budućnost tog biznisa u svojim rukama? Kad je vrijeme za zauzimanje čvrstog stava i na što ne pristajati ni za kakve novce, ispričao nam je Domagoj Ćorić, suosnivač Arkensighta. On nam je u Netokracijom podcastu ekskluzivno objavio veliku vijest kako je njegov startup najnoviji u portfelju tvrtki fonda Silicon Gardens.U sporednoj temi smo prešli na neke ležernije fenomene, točnije na ubojstvo virtualnog influencera sa svinjskom glavom Johna Porka kojeg je navodno ubio nekadašnji najbolji prijatelj AI generirani štakor Tim Cheese. Buru je u tom svijetu nedavno izazvala scena u kojoj se on ipak budi. Dio je to epske priče s Reelsa koja je još 2023. zaludila korisnike društvenih mreža._______________0:00 Uvod0:33 Investicija od 600.000 eura: svi ključni detalji5:30 Kako se dogovara investicija? Iza kulisa procesa14:30 Kako investitori procjenjuju startup?20:20 "Ne biraš lovu, već čovjeka iza love"26:10 Najčešće greške startupa u razgovorima s VC-jevima30:40 Što startupi NIKAD ne bi smjeli napraviti32:15 Kako je Izet "obrazovao" za investitora?34:00 Što donosi Silicon Gardens u 2025. + ključne lekcije za startupe38:50 O internetskom fenomenu John PorkuTOP i FLOP46:40 Svemir postaje smetlište48:30 Dvije afričke zemlje tuže Metu50:15 Idemo na Infobip Shift Miami!_______________

Never miss another webinar. Sign up here: https://imahealth.org/weekly-webinars/ Are digital IDs just a harmless modernization—or the cornerstone of a future built on surveillance and control? This week, IMA Senior Fellow Dr. Kat Lindley hosts Twila Brase, RN, PHN and Karen Bracken to explore how Real ID, vaccine passports, CBDCs, and digital ID systems could jeopardize personal autonomy, privacy, and medical freedom. With the May 7, 2025 Real ID deadline fast approaching, now is the time to understand what's at stake.Our guests will explain how these technologies are already being used to enforce compliance, restrict access, and centralize authority—and what individuals and states can do to push back. Drawing on real-world examples and constitutional principles, this webinar takes a vital look at the infrastructure being built around us, and the steps we must take to preserve freedom.On our website here - https://imahealth.org/digital-ids-a-threat-to-health-freedomTarget Keywords/tags: digital ids, health freedom• Donate: https://imahealth.org/donate/• Follow: https://imahealth.org/contact/• Webinar: https://imahealth.org/category/weekly-webinars/• Treatment: https://imahealth.org/treatment-protocols/• Medical Disclaimer: https://imahealth.org/about/terms-and-conditions/About IMA (Formerly FLCCC Alliance)The Independent Medical Alliance™ is a nonprofit, 501(c)(3) organization and coalition of physicians, nurses, and healthcare professionals united by a mission to restore trust and transparency in healthcare. The organization's mission is one driven by Honest Medicine™ that prioritizes patients above profits and emphasizes long-term wellness and disease prevention through empowerment of both physicians and their patients. With a focus on evidence-based medicine, informed consent, and systemic reform, IMA is driving a movement to create a more compassionate and effective healthcare system.For more information about the Independent Medical Alliance, visit www.IMAhealth.org

Biti majka nije uloga, to je nešto najlepše na svetu, ali nije sve što jedna žena može i treba da bude, priča u novoj Mamazjaniji Marta Lović, poznatija na mrežama kao Mada Faka Maka, mama četvoromesečnog Tadije, koji je njenom suprugu i njoj stigao kao „novogodišnji paketić“. Želja da postane majka, kod Marte se, kaže, javila, onda kad je shvatila da više ne želi da bude sebična. „Bilo je vreme da moje potrebe padnu na drugo mesto, prosto svi smo mi sebični dok smo mladi i bez dece i to je normalno i skroz u redu. Međutim, kad sam upoznala mog muža i zaljubila se, jako brzo smo se i venčali, poželela sam da tu ljubav podelimo sa trećim bićem, a onda i sa četvrtim, petim, videćemo“, sa osmehom priča naša gošća. Na nju nisu mnogo uticala upozorenja, predviđanja i zastrašivanja koja su stizala sa svih strana i koja često okružuju trudnice sa pričama o mogućim komplikacijama na porođaju, teškoćama sa bebom u prvim mesecima, problemima u braku zbog hormona, psiho-fizičkih promena i tome slično. „Očekivala sam da se nešto od toga obistini, ali nije, nekako je sve do sada išlo lagano i bez stresa. Tadija je divna beba, toliko da ne smem svima to da pričam jer ima majki koje mesecima ne spavaju. On se do ujutru ne budi, a zaspi u osam uveče. Dobro jede, veseo je, a sa nama učestvuje i u videima koji su duhovitog sadržaja. Nekako sa njim je sve lakše, daje nam dodatnu energiju i inspiraciju“. Ljubav i međusobna podrška između Marte i njenog supruga, doprineli su da i Tadija bude mirna i zadovoljna beba. „Verovatno ima veze sa našim odnosom u kući, jer nekako toliko smo ga želeli i bili presrećni kad se rodio, da beba to oseća. Kad nismo kod kuće, samo čekamo da se vratimo i da budemo sa njim jer nam nedostaje. Sve te priče da ću ‚tek videti kako će nam biti i šta me čeka‘, još se ne dešavaju, a nadam se i da neće, ali ljudi iz najbolje namere imaju potrebu da upozore, pa to nekad dobije neočekivne razmere i ne zvuči baš dobronamerno“, priča Marta. Ona ističe da je na porođaju, a kasnije sa bebom super prošla, ali da ima pomoć njene i Lazarove majke, pre svega, ali tu su i drugarice i ona i suprug koji sve dele. Ipak, nisu svi te sreće. „Ima žena koje su same sa detetom i nije im lako. Majke koje rade kao preduzetnice, recimo, nemaju nikakve benefite, niti privilegije u društvu, a o tome niko ne govori“. Takođe, ženama često treba pomoć nakon porođaja, jer nisu sve u dobrom psihičkom stanju, ističe ona, i normalno je da dođe do promena, ali ovde podrška izostaje, što mora da se menja. „Kao neko ko se bavi društvenim mrežama, meni nije bilo teško da se brzo vratim na posao, iz porodilišta sam snimala video i izvinjavala se pratiocima što kasnim, jer ‚eto, porodila sam se‘. Iako mi često treba predah i od mog posla, drugačije je onima koje rade same, vode firmu i izdržavaju porodicu. Previše očekivanja je danas na ženama, koje su i majke“, objašnjava Marta. Okolina je ta koja postavlja imperative i očekivanja. „Kad smo suprug i ja otišli jednom na rođendan, a Tadija je imao samo mesec dana, ‚razapeli‘ su me na mrežama. Kako sam mogla da ostavim dete, zašto foliram da se dobro provodim na rođendanu, kad je to nemoguće i tome slični komentari. Ljudi prosto sebi mnogo daju za pravo. Mi smo savesni i brižni roditelji, a imamo pravo i jedno na drugo, ipak smo nas dvoje par, a ljudi često zaborave da su u braku jer se opsesivno posvećuju deci. Dete je srećnije, ako su roditelji srećni, zadovoljni i ostvareni jer onda i sa decom imaju bolji i kvalitetniji odnos“, zaključuje Marta.

Never miss another webinar. Sign up here: https://imahealth.org/weekly-webinars/Learn more: https://imahealth.org/mrna-vaccines-myocarditis-concerns/Are COVID-19 vaccines linked to a higher risk of myocarditis? A new study says yes—and the findings are sounding alarms.Are COVID-19 vaccines linked to a higher risk of myocarditis? A new study by IMA Senior Fellows Dr. Jessica Rose and Dr. Kirk Milhoan says yes—and the findings are sounding alarms. Transparency in medicine is a key pillar of IMA's approach to healthcare reform, and the story of mRNA and myocarditis is a clear example of what can go wrong when Honest Medicine is lost.This week, Dr. Ryan Cole welcomes Dr. Rose for a deep-dive into the data and its implications—from molecular mimicry and spike protein toxicity to hospitalization rates and adolescent risk. It's a timely and urgent conversation that challenges the silence, demands accountability, and defends your right to informed consent.URL: https://imahealth.org/mrna-vaccines-myocarditis-concerns/• Donate: https://imahealth.org/donate/• Follow: https://imahealth.org/contact/• Webinar: https://imahealth.org/category/weekly-webinars/• Treatment: https://imahealth.org/treatment-protocols/• Medical Disclaimer: https://imahealth.org/about/terms-and-conditions/

James is joined by Emma Jones, the IMA's Head of Content, and Lisa Dutton, Head of Customer, to look back at the term just gone, and forward to the summer term to come.In this week's episode:The need to embrace ‘uncomfortable influencing'Tactical tips for managing difficult conversationsThe bunch of fives… what's the worst that can happen? What do CEO's think about Insight?The need to understand stakeholders and their communication preferencesWhat's on James's mind for Quirk's Chicago, London and New York?The next Insight forums we've organised for our members Please listen to find out more! This is episode 69 of the Transforming Insight podcast. If you have the ambition to transform your Insight team and the role it plays in your organisation, please tune in to future episodes. Not only will we explore the secrets of successful corporate Insight teams and their leaders, as outlined in James Wycherley's books, Transforming Insight and The Insight Leader's Playbook, we will also talk to senior corporate Insight leaders, delve into books that have inspired us, and discuss new best practice research carried out with the IMA's corporate members.You won't want to miss this! So please subscribe - and thank you for listening.  About James Wycherley, the author of Transforming Insight James Wycherley was Director of Customer Insight and Analytics at Barclays Bank from 2005 to 2015 when he became Chief Executive of the Insight Management Academy (IMA). He published his first book, Transforming Insight, in 2020, and his second, The Insight Leader's Playbook, in 2025, and he hosts the Insight forums and the Transforming Insight podcast.An entertaining keynote speaker, he has presented over 50 times at Quirk's events, a global record, and has provided thought leadership in the UK, USA, Europe, Canada, Australia, India and the Middle East.The Insight Management Academy is the world's leading authority on transforming corporate Insight teams, and its vision is to inspire and support every Insight leader to transform the impact of Insight in their organisation. Resources:If you would like more information on any of the ideas discussed in this episode of the Transforming Insight podcast, please visit www.insight-management.org DisclaimerThe Transforming Insight podcast is published by the Insight Management Academy and produced by Zorbiant.All rights reserved.   

Dr. Joseph Varon is a critical care physician, medical professor, and president of the Independent Medical Alliance (IMA), formerly the Front Line COVID-19 Critical Care Alliance (FLCCC). Their mission is to provide and advocate for patient rights, informed consent, and medical transparency, and they've played a major role supporting Health and Human Services Secretary Robert F. Kennedy Jr.“Hopefully, now with the new NIH director, we'll be able to fund some of these studies for these repurposed drugs that are really going to cut on cost of health care expenses,” he says.Varon has contributed to more than 950 peer-reviewed journal articles and is the editor-in-chief of multiple medical journals, including the newly launched Journal of Independent Medicine. In this episode, we dive into the IMA's recent work.“When you have, let's say, a paper that has 20 authors and out of those 20 authors, more than 90 percent of them are on the payroll of a specific pharmaceutical company that makes a product that you are studying, that's a conflict,” says Dr. Varon. “If we don't do something about the current state of medicine in our country, we're doomed. We're really doomed.”Views expressed in this video are opinions of the host and the guest, and do not necessarily reflect the views of The Epoch Times.

Never miss another webinar. Sign up here: https://imahealth.org/weekly-webinars/Lyme disease is rarely a solo infection. Many patients battle multiple pathogens at once—most commonly Bartonella and Babesia. So how do these stealth infections complicate recovery, and why are they so often missed?As part of IMA's commitment to tackling chronic disease, this week's webinar explores one of the most persistent and misunderstood conditions today. Join IMA Senior Fellow Dr. JP Saleeby for a conversation with Dr. Tom Moorcroft and Chris Jackman, FNP, as they uncover the hidden battle with Lyme co-infections. Learn how Bartonella and Babesia differ from Lyme, why they evade detection, and what today's practitioners are doing to improve testing and treatment strategies. If you're new to this world—or struggling with chronic symptoms—this episode is for you.Up on the IMA websiter here: https://imahealth.org/lyme-co-infections/• Donate: https://imahealth.org/donate/• Follow: https://imahealth.org/contact/• Webinar: https://imahealth.org/category/weekly-webinars/• Treatment: https://imahealth.org/treatment-protocols/• Medical Disclaimer: https://imahealth.org/about/terms-and-conditions/About IMA (Formerly FLCCC Alliance)The Independent Medical Alliance™ is a nonprofit, 501(c)(3) organization and coalition of physicians, nurses, and healthcare professionals united by a mission to restore trust and transparency in healthcare. The organization's mission is one driven by Honest Medicine™ that prioritizes patients above profits and emphasizes long-term wellness and disease prevention through empowerment of both physicians and their patients. With a focus on evidence-based medicine, informed consent, and systemic reform, IMA is driving a movement to create a more compassionate and effective healthcare system.For more information about the Independent Medical Alliance, visit www.IMAhealth.org

Lección 03 - Imágenes tomadas del matrimonio by La Voz de la Esperanza

Važno je da ljudi učine sve da održe porodicu, ali kad shvate da će biti srećniji odvojeni, onda treba da se raziđu, jer to je bolja opcija i za dete, priča gošća Mamazjanije i mama jedne Senje, Ivana Marinković “Frajerka”, koja je doktor filoloških nauka, zaposlena u Institutu za srpski jezik SANU, organizatorka venčanja, influenserka, a uz sve to, naglašava, uvek ima vremena za sebe i za svoje dete. Ivana se tokom razgovora osvrnula na bolne periode kada je pokušavala da održi i iznese trudnoću, ali, nažalost, nije uspevala. "Imala sam vanmateričnu trudnoću, potom i sponatni, a kad sam treći put ostala trudna, ležala sam dva meseca u bolnici. Hospitalizovana sam kad sam bila tek u petoj nedelji. Imam utisak da sam uspela, jer sam 'pustila', odnosno konačno sam se opustila i rekla sebi, ‘šta bude, biće'. Takođe sam se obraćala i bebi u sebi, i rekla joj da i ona mora malo da poradi na ovome", kroz osmeh priča Ivana. Ona je danas ponosna mama devetogodišnje Senje kojoj posvećuje najveći deo svog slobodnog vremena. "Imala sam neke poslovne ponude, ali sam ih odbila jer želim da provodim više vremena sa ćerkom dok je još mala. Aktivnost na mrežama je išla tom putanjom da mi oduzme dosta vremena, a već radim u Institutu i bavim se organizacijom venčanja i to je sve zajedno mnogo posla". Dodaje da kad ne radi i nije sa ćerkom, voli i sebi da udovolji, da se opusti i napuni baterije. "Bar pola sata dnevno odvojim samo za sebe, da izađem negde i popijem kafu. Mislim da je jako važno da žena bude ostvarena i zadovoljna da bi bila dobra mama", kaže Ivana. Nakon borbe da održi trudnoću, iz koje je stigla Senja, nažalost, došlo je do razvoda. "Ona je bila mala, a mi smo odlučili da se rastanemo. To nikad nije lako. Čovek sve čini da mu se porodica ne raspadne, nije to samo dvoje ljudi koji se razilaze, to je rascep porodice, a okolina krivicu uvek nekako svaljuje na ženu. Svakako, ne kajem se, jer mislim da je za dete daleko bolje da bude sa roditeljima koji su odvojeni, a srećni, nego da živi u disfunkcionalnoj zajednici", objašnjava Ivana. Opisuje i kako je ćerki dosta pomogla psihoterapija da prebrodi težak period. "Kad smo joj zajedno saopštili, počela je da se smeje, ali to je delovalo kao odbrambeni mehanizam deteta koje ne može odmah da prihvati tako drastičnu promenu", priča naša gošća. Ono što je problem su ljudi, koji i danas, u 21. veku, stigmatizuju samohrane majke. “Doživljavamo da u centru Beograda stičeš utisak da bi lakše prihvatili da žena, majka, ima pored sebe bilo kakvog muškarca, makar i onog koji je bije, samo da nije sama. Da je tu ta muška figura, kakva god i to je prosto neverovatno”, naglašava Ivana. U razgovoru je navela da ćerki pruža dosta slobode i da nije helikopter mama. “Ima nekih ljudi koji kažu da je 'nestašna', jer se popela na drvo, a ona je samo živahno dete, puno energije i deca treba da budu napolju, a ne da sede sa tabletom po ceo dan. Dogovorile smo se da može da koristi tablet pola sata radnim danima i sat vremena kad ne ide u školu. Za sad nekako uspeva, ali videćemo koliko će potrajati. Svakako, ono što želimo da naša deca budu i kako želimo da žive i da se ponašaju, treba mi prvo da pokažemo, jer je naš model taj na koji se ugledaju”, zaključuje Ivana “Frajerka”.

Never miss another webinar. Sign up here: https://imahealth.org/weekly-webinars/ What happens when leading voices in medicine, research, and patient advocacy come together to shape the future of healthcare? That's exactly what took place at the 2025 IMA Annual Conference—and If you couldn't make it, this is one webinar you won't want to miss.Join host Dr. Chris Martenson alongside IMA President and Chief Medical Officer Dr. Joe Varon, and IMA Senior Fellows Dr. Kat Lindley and Dr. Ryan Cole for a recap of this powerful gathering. They'll share behind-the-scenes stories, highlight standout sessions, and discuss what comes next for the Independent Medical Alliance and the growing Honest Medicine Movement. This is your chance to catch up on the energy, breakthroughs, and momentum that are driving our mission forward!On our website: https://imahealth.org/2025-ima-annual-conference-insights-whats-next/Keywords/Tags: IMA Annual Conference, IMA 2025• Donate: https://imahealth.org/donate/• Follow: https://imahealth.org/contact/• Webinar: https://imahealth.org/category/weekly-webinars/• Treatment: https://imahealth.org/treatment-protocols/• Medical Disclaimer: https://imahealth.org/about/terms-and-conditions/About IMA (Formerly FLCCC Alliance)The Independent Medical Alliance™ is a nonprofit, 501(c)(3) organization and coalition of physicians, nurses, and healthcare professionals united by a mission to restore trust and transparency in healthcare. The organization's mission is one driven by Honest Medicine™ that prioritizes patients above profits and emphasizes long-term wellness and disease prevention through empowerment of both physicians and their patients. With a focus on evidence-based medicine, informed consent, and systemic reform, IMA is driving a movement to create a more compassionate and effective healthcare system.For more information about the Independent Medical Alliance, visit www.IMAhealth.org

[깊이 있는 경제뉴스] 1) 관세 90일 유예에 증시 폭등.. 환율·유가는 롤러코스터 2) 정부 “자동차 산업에 긴급 지원”.. 전기차 보조금도 ↑ 3) 원금 손실 없는 ‘IMA 상품' 나온다.. 내용은? - 박세훈 작가 - 손석우 경제뉴스 큐레이터 - 김현우 행복자산관리연구소 소장

Nije normalno da mame postižu sve svakoga dana, rastrzane smo, a potrebno je da imamo vremena za sebe, priča u novoj Mamazjaniji influenserka Aleksandra Golijan, poznatija na mrežama kao „Nanamamasita“, koja je mama tri devojčice, a uči ih da su jedna drugoj najbolje drugarice i najveće bogatstvo - i sa kojima nikad nije dosadno. Kod Aleksandre u kući, dinamike, buke, pitanja, odgovora, razgovora, druženja, ne nedostaje, sa tri devojčice, koje neretko okupljaju i svoje drugarice, pa žurka ne prestaje. „Njihove drugarice su često kod nas, ostaju i da prespavaju, pa je to zabava bez prestanka, ali navikli smo na gužvu, tako da dok su dobre i lepo se zabavljaju ništa nije teško. Osim, što kad završe sa igrom, neko mora da raskloni haos“, uz osmeh priča Aleksandra. U dvadesetim godinama rodila je sve tri ćerke i kaže da je to nešto najbolje što je u životu uradila, jer danas je mlada mama, a one su već velike i mogu da se druže, putuju, bez nervoze i premora. „Rodila sam prvu ćerku sa 22, kroz par godina drugu, a uskoro i treću. Sa drugim detetom je teže, a sa trećim nije uopšte bilo lako, jer sam bila baš umorna. Ipak, drago mi je što sam bila mlada, iako ne mislim da je to najvažnije. Na dete se odlučujete kad imate pravog partnera, osobu sa kojom želite da imate decu, bez obzira na godine“, kaže naša gošća. Za decu je presudan model koji im pružamo, kao i međusobni odnos roditelja, ističe ona. „Deca su ogledalo kuće i života i ponašanja roditelja. Mi smo smireni, tolerantni, trudimo se da ne budemo nervozni, napeti sa decom, da na njih ne prenosimo loše raspoloženje, jer to je način da odrastaju u zdrave ljude“. Škola jeste važna, ali nije najvažnija. „Jednom me je najstarija ćerka slagala za ocenu i rasplakala sam se. Sebe sam iznenadila takvom reakcijom, ali nisam je očekivala, niti od nje da me slaže. To se više nije ponovilo. Čudno je zato što ih učm baš da ocene nisu najvažnije, već društvo u kojem se nalaze jer to je neki temelj za srećan život, pre nego uspeh u školi, koji ne garantuje i uspeh u životu“, priča Aleksandra. U eri interneta i njenog rada, koji pratimo na Instagramu, teško je decu odvojiti od telefona, ali ona, ipak, nekako uspeva. „Ne provode previše vremena na mrežama, uče, izlaze napolje, bave se sportom, tako da sa ograničavanjem vremena na telefonu nemamo problem. Ono što se, inače, često vidi na Instagramu nije realna slika života. Ima žena koje se snimaju kako se bude u tri ujutru ili u pet, pa treniraju, spremaju hranu, bude decu u zoru, a ona kao ustaju bez problema. Kad to vidite, znate da nešto nije u redu. Ipak, ko stvarno može tako i nije mu teret, svaka čast“, objašnjava Aleksandra. Ćerke uči da jedna drugoj treba da budu najbolje drugarice i da je to što imaju jedna drugu neprocenjivo bogatstvo. „Uvek sam želela sestru, a evo sad imam tri ćerke koje su moj najveći životni uspeh i želim da budu svesne koliko su srećne što imaju jedna drugu. Tome ih učim, kao što one mene uče da budem dosledna, strpljiva i prenose mi neke kvalitete i osobine, koje pre njih nisam posedovala, a i od dece ponekad treba učiti“, zaključuje Aleksandra.

Quatrième Pyramide d'Égypte ou 7è colonne du temple romain de Jupiter à Baalbek : l'Égyptienne Oum Kalsoum et la Libanaise Fayrouz nourrissent toujours l'inconscient collectif arabe. Et la littérature. (Rediffusion) Avec Ysabel Saiah Baudis et Marjorie Bertin qui ont écrit respectivement sur Oum Kalsoum et Fayrouz.Notre 1ère invitée est la journaliste Marjorie Bertin (qui travaille à RFI) pour la parution de « Fayrouz, Moi je chante l'humanité », aux éditions Orients.Elle est considérée comme la dernière légende vivante du monde arabe. « Ambassadrice du Liban à travers le monde », Fayrouz a enregistré plus de 800 chansons, sorti une cinquantaine d'albums et joué dans une vingtaine de films et de comédies musicales. Celle qui refusa de quitter son pays pendant la guerre civile libanaise incarne plus qu'aucune autre chanteuse un symbole de paix et d'espoir. Pourtant, on en sait peu sur elle, épouse d'Assi Rahbani, qui avec son frère Mansour révolutionna la musique libanaise du XXème siècle. Son fils Ziad, artiste engagé et enfant prodige de la scène libanaise, assurera le tournant jazz de la carrière de sa mère à partir de la fin des années 1970.Comment Fayrouz est-elle devenue la dernière icône révérée dans tout le monde arabe ? Pour la première fois, un livre en français retrace l'histoire de cette chanteuse légendaire. Titres joués :Atini el nay wa ghani (Donne-moi la flûte et chante) d'après Khalil GibranAbbaytak belsaif (Je t'ai aimé l'été)Kifak inta (qui marque le tournant de sa musique avec son fils Ziad)Li Beyrouth (concerto d'Aranjuez et magnifique poème sur la ville, sorti pendant la guerre).► Culture Prime Fayrouz► « Fayrouz, Moi je chante l'humanité » chez Orients   Puis nous recevons la journaliste et éditrice Ysabel Saiah Baudis, qui réédite « Oum Kalsoum, l'étoile de l'Orient » « Elle est toujours vivante ! », confie Ysabel Saïah Baudis. C'est la nature des génies, car cela fait  50 ans que la diva égyptienne est décédée (3 février 1975) et pourtant, on l'entend, on la voit, elle tagguée, reprise, commentée. Sa vie est digne des plus beaux contes orientaux : née pauvre, paysanne, fille d'un religieux, elle possède un don qu'elle cultivera grâce à sa farouche détermination. La chance aidant, elle rencontrera les plus grands poètes et musiciens qui l'accompagneront dans son ascension. Adulée de son vivant par le président de l'Égypte aussi bien que par l'homme du peuple, elle accompagnera toutes les luttes de liberté, d'instruction, d'ouverture et de progrès techniques du XXème siècle. Elle reste la Voix qui guide et réunit tout le monde arabe.À l'occasion des 50 ans de sa disparition, la Philharmonie de Paris propose une semaine spéciale avec concert hommage le 2 février.Extraits joués : Al Atlal, Weddad, 1ère comédie musicale de la diva.► Philharmonie de Paris du 30 janvier au 2 février ► IMA ► Olympia Paris 1967 ► Orients Éditions ► Culture Prime Oum.

Od žene u diplomatiji postala je žena na sceni koja komedijom ruši patrijarhalne predrasude, što na neki način radi i u privatnom životu, Jagoda Jovanović, stend ap komičarka koja piše priče. Sa mužem Špancem odgaja dva dečaka, koja nose neobično lepa imena, Kai i Nil, žive u Srbiji, ali često skoknu i do Barselone, obišli su svet, a na međusobnoj podršci i poruci koju šalju svojim odnosom prema poslu i deci, možemo samo da im pozavidimo ili da se prosto – ugledamo. Jagoda nam je u razgovoru otkrila kako izgleda život u mešovitom braku u Srbiji. „Posebno je zanimljivo što sam udata za Španca, čija je mama feministiknja, tako da sam dobila gotov proizvod“, uz osmeh priča Jagoda. Priznaje da bi joj bilo teško sa severnjakom, jer kako kaže, u tim hladnim zemljama u kojima nema sunca na nebu, nema ga ni u ljudima. „Španci i mi smo dosta slični, pa smo se lako uklopili. Posebno što je generacija mog supruga već odmakla od tog patrijarhalnog načina života, koji je u Španiji, pod vekovnim uticajem crkve, bio jako izražen. Međutim, sad je sve dosta drugačije, a on mi je u životu, sa decom, ali i u poslu, velika podrška“. Jagoda i Pao izvodili su zajedno nastup „Iz špajza na scenu“, a u velikom broju njenih stend-apova i priča, on je tema, kao i njihov brak. „Navikao je da bude tema u mojim stend-apovima i ne smeta mu. Ima, naravno, dušebrižnika koji kažu da treba da nađem pravog muškarca, da je Pao dobar, ali nosi helanke. Kade je to čuo, predložio je da se na sceni jednom prilikom i pojavi u helankama“, kroz osmeh priča naša gošća, i dodaje da njoj kažu da radi stend ap, ali da je Pao taj koji je duhovit. Njih dvoje, pre četiri godine, dobili su prvo dete. Jagoda je sa 37 godina rodila prvog sina, a već sa 39 drugog i to -nije bilo lako. „Bila sam ljuta kad sam saznala za drugu trudnoću, ali Pao je to razumeo. Kai godinu dana uopšte nije spavao, a kad je roditelj neispavan, pravi greške, nemaran je, i eto, tako dođe i do drugog deteta. Mnogi kažu da je razlika u godinama između njih dvojice idealna, ali ne bih se složila. Nisam imala takve planove, opet, obojica su divni i oni su mi sad najveća inspiracija za rad, uprkos svemu“, priča Jagoda. Njena knjiga „Ljubav, Uživo“ je dokaz. Opisuje upravo porodične odnose i ljubav prema deci. „Istina je da deca frustriraju i da je u kući ponekad napeto, ali nekako sve to lakše podnosim kad te situacije iskoristim u stend-apu i mom pisanju. Takođe, Pao je divan, on je mnogo smireniji od mene i kad se iznerviram, umiri me i sa decom je jako brižan i strpljiv“, kaže Jagoda. Oko vaspitanja dece se slažu i nema mnogo odstupanja. „Ne volim one helikopter roditelje, koji na sve paze i guše decu. Na nas vrište kad vide kako ih puštamo da trče, jure, budu svoji. Ako dete ne padne, neće umeti ni da ustane, treba da oseti i kako je to, a kako će, ako mu ne damo da izađe napolje. A deca treba da budu napolju, da se umore. Da dođu kući mrtvi umorni, a živi“, naglašava Jagoda. Tokom našeg razgovora, Jagoda je ispričala kako zvuče njihova deca, koja imaju četiri i dve godine, a govore srpski i španski paralelno i često ih mešaju u istim rečenicama, i objasnila koliko je značajno za decu, da znaju više jezika od malena, ali i da nikada ne zaborave maternji. Takođe, osim njene dece, koja su joj stalna inspiracija, nedavno je dobila još jednu. „Ovo što studenti u Srbiji rade je donelo novu motivaciju za rad i nepresušnu inspiraciju za priče i stend-apove, dok uz sve to gajimo nadu da će uspeti i da će se nešto promeniti, da će nas zaista ta naša deca naučiti onome što mi nismo mogli njih i popraviti ono u čemu smo mi podbacili“, zaključuje Jagoda, sa širokim, neizostavnim osmehom.

Never miss another webinar. Sign up here: https://imahealth.org/category/weekly-webinars/ What you eat could be the key to unlocking more energy, better health, and even a longer life. But how do you separate food facts from fiction in a world filled with ultra-processed products and fad diets?This week, IMA Senior Fellows Dr. JP Saleeby and Dr. Kristina Carman sit down to explore how a nutrient-rich diet can improve energy, reduce inflammation, and support long-term wellness. From busting myths about ultra-processed foods to highlighting the best superfoods for longevity, they'll share practical advice to help patients and providers shift toward sustainable, food-first choices that really make a difference.IMA Website URL: https://imahealth.org/nutrient-rich-diet-energy-longevity/• Donate: https://imahealth.org/donate/• Follow: https://imahealth.org/contact/• Webinar: https://imahealth.org/category/weekly-webinars/• Treatment: https://imahealth.org/treatment-protocols/• Medical Disclaimer: https://imahealth.org/about/terms-and-conditions/About IMA (Formerly FLCCC Alliance)The Independent Medical Alliance™ is a nonprofit, 501(c)(3) organization and coalition of physicians, nurses, and healthcare professionals united by a mission to restore trust and transparency in healthcare. The organization's mission is one driven by Honest Medicine™ that prioritizes patients above profits and emphasizes long-term wellness and disease prevention through empowerment of both physicians and their patients. With a focus on evidence-based medicine, informed consent, and systemic reform, IMA is driving a movement to create a more compassionate and effective healthcare system.For more information about the Independent Medical Alliance, visit www.IMAhealth.org

IMA will reject all Heng Sheng applications if investigations reveal evidence of owner financing or under-selling citizenship investments.View the full article here.Subscribe to the IMI Daily newsletter here.

Learn more: https://imahealth.org/measles-vaccine-scheduleMeasles and MMR vaccines are dominating the news, but what are the real risks of measles? What treatment options exist? And how does this moment relate to the ongoing conversation about the childhood vaccine schedule?This week, IMA President & Chief Medical Officer Dr. Joseph Varon hosts an essential discussion with pediatricians and IMA Senior Fellows Dr. Elizabeth Mumper and Dr. Renata Moon. They'll break down the true risks of measles, the immune system's natural response, and treatment options to support childhood immunity. The discussion will also explore how media narratives influence public perception of measles outbreaks and what parents need to know about childhood vaccine schedules.Don't miss this critical conversation with doctors who prioritize patient safety, transparency, and informed decision-making in pediatric care.URL: https://imahealth.org/measles-vaccine-scheduleKeywords/tags: measles vaccine schedule• Donate: https://imahealth.org/donate/• Follow: https://imahealth.org/contact/• Webinar: https://imahealth.org/category/weekly-webinars/• Treatment: https://imahealth.org/treatment-protocols/• Medical Disclaimer: https://imahealth.org/about/terms-and-conditions/About IMA (Formerly FLCCC Alliance)The Independent Medical Alliance™ is a nonprofit, 501(c)(3) organization and coalition of physicians, nurses, and healthcare professionals united by a mission to restore trust and transparency in healthcare. The organization's mission is one driven by Honest Medicine™ that prioritizes patients above profits and emphasizes long-term wellness and disease prevention through empowerment of both physicians and their patients. With a focus on evidence-based medicine, informed consent, and systemic reform, IMA is driving a movement to create a more compassionate and effective healthcare system.For more information about the Independent Medical Alliance, visit www.IMAhealth.org

Learn more: https://imahealth.org/rethinking-virus-treatment-and-vaccines/Are public health agencies prioritizing science—or fear? From flu treatment guidelines to fear-driven vaccine campaigns, the public has been fed conflicting messages for years. But what's really behind these decisions?This week, IMA Senior Fellow Dr. Ryan Cole sits down with Dr. Robert Malone for a deep dive into how public health narratives shape virus treatments and vaccine policies. They'll break down why the CDC combines pneumonia and flu deaths, alternative approaches to flu treatment, and the alarming role of fear in vaccine marketing.The conversation will also cover the FDA's decision to cancel its flu strain selection meeting, the response to the recent measles "outbreak," and what might change under a new HHS. Don't miss this crucial discussion with two of the most outspoken experts in medicine.• Donate: https://imahealth.org/donate/• Follow: https://imahealth.org/contact/• Webinar: https://imahealth.org/category/weekly-webinars/• Treatment: https://imahealth.org/treatment-protocols/• Medical Disclaimer: https://imahealth.org/about/terms-and-conditions/About IMA (Formerly FLCCC Alliance)The Independent Medical Alliance™ is a nonprofit, 501(c)(3) organization and coalition of physicians, nurses, and healthcare professionals united by a mission to restore trust and transparency in healthcare. The organization's mission is one driven by Honest Medicine™ that prioritizes patients above profits and emphasizes long-term wellness and disease prevention through empowerment of both physicians and their patients. With a focus on evidence-based medicine, informed consent, and systemic reform, IMA is driving a movement to create a more compassionate and effective healthcare system.For more information about the Independent Medical Alliance, visit www.IMAhealth.org

02/28/25: Joel Heitkamp is out of the studio, and the Jamie Selzler takes over for the morning. Jamie is joined by Dr. Brent Hella from IMA Healthcare. Dr. Hella is an IMA physician who specializes in disease management with a special interest in diabetes and weight loss management. They talk about weight loss medication and how they work. (Joel Heitkamp is a talk show host on the Mighty 790 KFGO in Fargo-Moorhead. His award-winning program, “News & Views,” can be heard weekdays from 8 – 11 a.m. Follow Joel on X/Twitter @JoelKFGO.)See omnystudio.com/listener for privacy information.